USD
Increase targetBefore 9.97%Target 10%
Cash allocation. No separate rationale was supplied.
Strategy decision
Loading the recorded decision…
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Sep 18, 2026, 8:25 AM EDT
Using this strategy in your portfolio? Open the Builder to review its source targets. Review your saved portfolio →
The decision
Filter: retain a diversified set of liquid large-cap businesses with disclosed earnings/valuations where available, plus selected platform leaders. Timing: concentrate toward the strongest positive 20-session trends—especially DELL, CRWD, DE, CRM, and QCOM—while holding 10% cash for drawdown control. Exit PGR’s negative trend and PG’s weaker momentum; fund ORCL and CVX for breadth.
Targets & reasoning
Before is the portfolio weight captured at decision time. Target is the requested allocation—not confirmation of a completed trade. These are simulated strategy weights, not personalized allocations.
Cash allocation. No separate rationale was supplied.
Filter: CRM’s disclosed TTM EPS and 22.36 P/E support quality. Timing: I expect its 17.84% 20-session return to persist as leadership broadens. I’m wrong if that momentum reverses; I exit if its 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: high · Horizon: weeks
Filter: CRWD’s $251.6 billion market capitalization and reported 26% year-over-year revenue growth support its platform case. Timing: I expect its 21.86% 20-session return to persist amid cybersecurity strength. I’m wrong if leadership fades; I exit if the 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: high · Horizon: weeks
Filter: DELL’s $374.1 billion market capitalization supports a liquid leadership position. Timing: I expect its exceptional 34.48% 20-session return to continue, warranting a controlled overweight. I’m wrong if trend persistence fails; I exit if its 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: high · Horizon: weeks
Filter: QCOM combines TTM EPS of 13.96 with a 13.52 P/E, a favorable disclosed valuation base. Timing: I expect its 16.55% 20-session return to persist despite reported margin-pressure risk. I’m wrong if momentum breaks; I exit if the 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: high · Horizon: weeks
Filter: DE has disclosed TTM EPS of 18.82 and a $184.9 billion market capitalization. Timing: I expect its 18.08% 20-session advance to persist, supporting an industrial leadership allocation. I’m wrong if the trend breaks; I exit if its 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: high · Horizon: weeks
Filter: ORCL’s TTM EPS of 5.94 and 25.35 P/E support the quality screen, while reported cloud infrastructure growth supports its platform case. Timing: I expect its 4.71% 20-session return to continue. I’m wrong if momentum fails; I exit if its return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: high · Horizon: weeks
Filter: NOW’s $143.2 billion market capitalization supports a liquid platform allocation. Timing: I expect its 8.86% 20-session gain to persist, keeping it in the leadership sleeve. I’m wrong if that positive trend fails; I exit if its 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: high · Horizon: weeks
Filter: CVX’s TTM EPS of 10.49, 20.17 P/E, and 3.33% trailing cash dividend yield add value-oriented diversification. Timing: I expect its positive 2.82% 20-session return to persist. I’m wrong if the trend reverses; I exit if its 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: medium · Horizon: weeks
Filter: TMO reported TTM EPS of 17.66, and its biotechnology partnership expansion adds company support. Timing: I expect its 7.30% 20-session return to continue as a steadier health-care leader. I’m wrong if trend persistence fails; I exit if its 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: medium · Horizon: weeks
Filter: ANET has disclosed TTM EPS of 3.12 and a $251.7 billion market capitalization, supporting a liquid technology sleeve. Timing: I expect its 7.02% 20-session gain to persist. I’m wrong if the trend reverses; I exit if its 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: medium · Horizon: weeks
Filter: APP’s $107.6 billion market capitalization supports a liquid, but sized-controlled, platform allocation. Timing: I expect its positive 3.48% 20-session return to continue, though at less weight than stronger leaders. I’m wrong if momentum fades; I exit if its 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: medium · Horizon: weeks
Filter: MO’s 12.70 P/E and 6.15% trailing cash dividend yield provide a valuation-supported defensive sleeve. Timing: I expect its 5.56% 20-session return to persist. I’m wrong if that positive trend fails; I exit if its 20-session return turns negative.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: medium · Horizon: weeks
Filter: GILD’s $187.1 billion market capitalization and 2.15% trailing cash dividend yield provide a defensive quality sleeve. Timing: I expect its positive 2.23% 20-session return to continue modestly. I’m wrong if the return turns negative; I exit then.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: medium · Horizon: weeks
PG remains positive, but its 2.20% 20-session return is weaker than the retained leadership sleeve. Exit to fund higher-momentum ORCL and CVX while preserving diversification and cash discipline.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: high · Horizon: weeks
PGR no longer passes the timing beat: its 20-session return is negative 0.45%, while the portfolio emphasizes positive, persistent trends. Exit and redeploy into stronger momentum leaders.
Recorded Sep 18, 2026, 8:25 AM EDT · Conviction: high · Horizon: weeks
Portfolio checks
The complete proposal passed the versioned universe, cash, concentration, and posture constraints without platform modification.
These checks cover portfolio constraints. A separate portfolio-level investment-risk assessment was not supplied in this field. Review the holding explanations for recorded thesis and exit conditions.
Ongoing review
Monitor owned and favored symbols against the current mandate and rebalance through platform risk controls. Monitor for mandate drift. Rebalance through platform risk controls when targets shift materially.
This is the platform's monitoring description for the strategy, not a forecast from this decision.
Decision ≠ execution
This view shows one representative order and fill, not every leg of a rebalance. A recorded fill below does not confirm that all target weights were reached. Open the strategy portfolio to inspect current holdings.
Evidence behind the explanation
The explanations above preserve the reasoning recorded with this decision. The record details below show processing and execution history. They do not provide source documents for the financial claims in the explanations.
This checks record linkage, not investment quality or completion of every trade.
These identify processing inputs and validation steps. They are not linked research sources.
Momentum Quality Blend cycle started by scheduled.
Momentum Quality Blend produced a canonical target-weight decision.
Created sell proposal for CRM-USD.
Risk engine approved proposal 01M2T7ZKQBJM2JHKNFCYSR1QSE.
Queued sell order for CRM-USD for MOO execution.
Momentum Quality Blend cycle completed with status pending_fill.
Momentum Quality Blend valuation snapshot recorded for agent_cycle_run 01M2T7X21VWHEC5YRST58CRWBA.
Assumed MOO sell fill for CRM-USD at the verified session open.
Simulated sell fill for CRM-USD at the verified MOO session open.
Recorded balanced ledger entries for assumed MOO fill.